{"id":22248,"date":"2022-08-17T23:19:17","date_gmt":"2022-08-17T21:19:17","guid":{"rendered":"https:\/\/kapitalpartner.dk\/?p=22248"},"modified":"2022-08-18T15:50:03","modified_gmt":"2022-08-18T13:50:03","slug":"every-year-2500-danes-are-affected-and-270-die","status":"publish","type":"post","link":"https:\/\/kapitalpartner.dk\/en\/every-year-2500-danes-are-affected-and-270-die\/","title":{"rendered":"Every year 2,500 Danes are affected and 270 die"},"content":{"rendered":"\n<p><strong>In Denmark alone, 270 people die each year from birthmark cancer, the most common cancer in the 15-34 age group, and 2,500 new cases are registered each year. It costs Danish society alone 250 million DKK. &#8211; every year. For this reason alone, Evaxion Biotech is an interesting company that is currently enrolling the first patients in its Phase IIb study.<\/strong><\/p>\n\n\n\n<p>US-listed Danish biotech company Evaxion Biotech [EVAX &#8211; price 3.39] has published its half-year report for 2022. It contains &#8211; for regulatory reasons &#8211; nothing new, but is a good reason to summarise the investment case.<\/p>\n\n\n\n<p><strong>USD 25 million in cash<\/strong><\/p>\n\n\n\n<p>Evaxion Biotech has USD 25 million in cash on hand, which extends beyond 12 months, and has USD 40 million in back-up financing. It is therefore not a company that needs to raise capital, which puts Evaxion Biotech in a significantly better position than many other biotech companies. Nevertheless, the share price has fallen with the market, but has shown very good progress over the summer.<\/p>\n\n\n\n<p><strong>Price development year-to-date: Evaxion Biotech &amp; C25 index<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-YTD-C25.png\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1010\" height=\"570\" src=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-YTD-C25.png\" alt=\"\" class=\"wp-image-22054\" srcset=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-YTD-C25.png 1010w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-YTD-C25-300x169.png 300w, https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-YTD-C25-768x433.png 768w\" sizes=\"(max-width: 1010px) 100vw, 1010px\" \/><\/a><\/figure>\n\n\n\n<p><strong>Partner in sight<\/strong><\/p>\n\n\n\n<p>The business model is to out-license the projects to a partner\/pharmaceutical company once the projects are through Phase II. The initiation of the Phase IIb study with the EVX-01 programme (treatment of metastatic\/spreading melanoma) in combination with Merck&#8217;s KEYTRUDA inhibitor could be the first programme to be out-licensed &#8211; and Merck would be an obvious partner.<\/p>\n\n\n\n<p><strong>There&#8217;s an interesting news flow ahead<br><\/strong>In addition to the Phase IIb study, news on regulatory filings for new programmes is expected in this half year and data from the Phase 1\/2a study for the EVX-02 programme in patients with mantle cell cancer who have undergone surgery is expected in H1 2023.<\/p>\n\n\n\n<p><strong>Expansion of the pipeline<\/strong><\/p>\n\n\n\n<p>Molecular cancer is currently the mainstay of the investment case in Evaxion Biotech, but the pipeline is being expanded with new indications. These include the EVX-03 programme for the treatment of lung cancer and, most recently, the EVX-B2 programme for the treatment of gonorrhoea.<\/p>\n\n\n\n<p class=\"has-vivid-red-color has-text-color\"><a href=\"https:\/\/kapitalpartner.dk\/en\/evaxion-biotech\/\">Read more about the investment case of Evaxion Biotech here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In Denmark alone, 270 people die each year from birthmark cancer, the most common cancer in the 15-34 age group, and 2,500 new cases are registered each year. It costs Danish society alone 250 million DKK. &#8211; every year. For this reason alone, Evaxion Biotech is an interesting company that is currently enrolling the first [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":22058,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[151,29],"tags":[],"class_list":["post-22248","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-cases","category-investeringscases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Every year 2,500 Danes are affected and 270 die | Kapital Partner A\/S<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Every year 2,500 Danes are affected and 270 die | Kapital Partner A\/S\" \/>\n<meta property=\"og:description\" content=\"In Denmark alone, 270 people die each year from birthmark cancer, the most common cancer in the 15-34 age group, and 2,500 new cases are registered each year. It costs Danish society alone 250 million DKK. &#8211; every year. For this reason alone, Evaxion Biotech is an interesting company that is currently enrolling the first [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/\" \/>\n<meta property=\"og:site_name\" content=\"Kapital Partner A\/S\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/kapitalpartner\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-17T21:19:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-08-18T13:50:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"537\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Anders S\u00f8ndergaard\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@KapitalPartner\" \/>\n<meta name=\"twitter:site\" content=\"@KapitalPartner\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Anders S\u00f8ndergaard\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/\"},\"author\":{\"name\":\"Anders S\u00f8ndergaard\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed\"},\"headline\":\"Every year 2,500 Danes are affected and 270 die\",\"datePublished\":\"2022-08-17T21:19:17+00:00\",\"dateModified\":\"2022-08-18T13:50:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/\"},\"wordCount\":346,\"publisher\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg\",\"articleSection\":[\"Company cases\",\"Investeringscases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/\",\"url\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/\",\"name\":\"Every year 2,500 Danes are affected and 270 die | Kapital Partner A\/S\",\"isPartOf\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg\",\"datePublished\":\"2022-08-17T21:19:17+00:00\",\"dateModified\":\"2022-08-18T13:50:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage\",\"url\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg\",\"contentUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg\",\"width\":800,\"height\":537},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kapitalpartner.dk\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investeringscases\",\"item\":\"https:\/\/kapitalpartner.dk\/category\/investeringscases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Selskabscases\",\"item\":\"https:\/\/kapitalpartner.dk\/category\/investeringscases\/selskabscases\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Every year 2,500 Danes are affected and 270 die\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kapitalpartner.dk\/#website\",\"url\":\"https:\/\/kapitalpartner.dk\/\",\"name\":\"Kapital Partner A\/S\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kapitalpartner.dk\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/kapitalpartner.dk\/#organization\",\"name\":\"Kapital Partner A\/S\",\"url\":\"https:\/\/kapitalpartner.dk\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png\",\"contentUrl\":\"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png\",\"width\":496,\"height\":432,\"caption\":\"Kapital Partner A\/S\"},\"image\":{\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/kapitalpartner\",\"https:\/\/x.com\/KapitalPartner\",\"https:\/\/www.linkedin.com\/company\/10438322\",\"https:\/\/www.youtube.com\/channel\/UCODuY5PE_fxmp2nSSsq3l3w\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed\",\"name\":\"Anders S\u00f8ndergaard\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kapitalpartner.dk\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g\",\"caption\":\"Anders S\u00f8ndergaard\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Every year 2,500 Danes are affected and 270 die | Kapital Partner A\/S","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/","og_locale":"en_US","og_type":"article","og_title":"Every year 2,500 Danes are affected and 270 die | Kapital Partner A\/S","og_description":"In Denmark alone, 270 people die each year from birthmark cancer, the most common cancer in the 15-34 age group, and 2,500 new cases are registered each year. It costs Danish society alone 250 million DKK. &#8211; every year. For this reason alone, Evaxion Biotech is an interesting company that is currently enrolling the first [&hellip;]","og_url":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/","og_site_name":"Kapital Partner A\/S","article_publisher":"https:\/\/www.facebook.com\/kapitalpartner","article_published_time":"2022-08-17T21:19:17+00:00","article_modified_time":"2022-08-18T13:50:03+00:00","og_image":[{"width":800,"height":537,"url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg","type":"image\/jpeg"}],"author":"Anders S\u00f8ndergaard","twitter_card":"summary_large_image","twitter_creator":"@KapitalPartner","twitter_site":"@KapitalPartner","twitter_misc":{"Written by":"Anders S\u00f8ndergaard","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#article","isPartOf":{"@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/"},"author":{"name":"Anders S\u00f8ndergaard","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed"},"headline":"Every year 2,500 Danes are affected and 270 die","datePublished":"2022-08-17T21:19:17+00:00","dateModified":"2022-08-18T13:50:03+00:00","mainEntityOfPage":{"@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/"},"wordCount":346,"publisher":{"@id":"https:\/\/kapitalpartner.dk\/#organization"},"image":{"@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage"},"thumbnailUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg","articleSection":["Company cases","Investeringscases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/","url":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/","name":"Every year 2,500 Danes are affected and 270 die | Kapital Partner A\/S","isPartOf":{"@id":"https:\/\/kapitalpartner.dk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage"},"image":{"@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage"},"thumbnailUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg","datePublished":"2022-08-17T21:19:17+00:00","dateModified":"2022-08-18T13:50:03+00:00","breadcrumb":{"@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#primaryimage","url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg","contentUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2022\/08\/Evaxion-Biotech-modermaerkekraeft-1.jpg","width":800,"height":537},{"@type":"BreadcrumbList","@id":"https:\/\/kapitalpartner.dk\/hvert-aar-rammes-2-500-danskere-og-270-doer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kapitalpartner.dk\/en\/"},{"@type":"ListItem","position":2,"name":"Investeringscases","item":"https:\/\/kapitalpartner.dk\/category\/investeringscases\/"},{"@type":"ListItem","position":3,"name":"Selskabscases","item":"https:\/\/kapitalpartner.dk\/category\/investeringscases\/selskabscases\/"},{"@type":"ListItem","position":4,"name":"Every year 2,500 Danes are affected and 270 die"}]},{"@type":"WebSite","@id":"https:\/\/kapitalpartner.dk\/#website","url":"https:\/\/kapitalpartner.dk\/","name":"Kapital Partner A\/S","description":"","publisher":{"@id":"https:\/\/kapitalpartner.dk\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kapitalpartner.dk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kapitalpartner.dk\/#organization","name":"Kapital Partner A\/S","url":"https:\/\/kapitalpartner.dk\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/","url":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png","contentUrl":"https:\/\/kapitalpartner.dk\/wp-content\/uploads\/2021\/10\/Vandret-logo-PNG.png","width":496,"height":432,"caption":"Kapital Partner A\/S"},"image":{"@id":"https:\/\/kapitalpartner.dk\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/kapitalpartner","https:\/\/x.com\/KapitalPartner","https:\/\/www.linkedin.com\/company\/10438322","https:\/\/www.youtube.com\/channel\/UCODuY5PE_fxmp2nSSsq3l3w"]},{"@type":"Person","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/3225264862e39be271a9aff1c94009ed","name":"Anders S\u00f8ndergaard","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kapitalpartner.dk\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/27b1d0514d528cdb7505c72f554afadc?s=96&d=mm&r=g","caption":"Anders S\u00f8ndergaard"}}]}},"_links":{"self":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/22248"}],"collection":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/comments?post=22248"}],"version-history":[{"count":2,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/22248\/revisions"}],"predecessor-version":[{"id":22251,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/posts\/22248\/revisions\/22251"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/media\/22058"}],"wp:attachment":[{"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/media?parent=22248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/categories?post=22248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kapitalpartner.dk\/en\/wp-json\/wp\/v2\/tags?post=22248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}